Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Ultrasensitive test detects corrupted protein associated with Alzheimer's and CTE

Ultrasensitive test detects corrupted protein associated with Alzheimer's and CTE

European scientists aim to identify causes of dementia

European scientists aim to identify causes of dementia

Tau protein reduces neural activity in Alzheimer's mouse models

Tau protein reduces neural activity in Alzheimer's mouse models

FAU Brain Institute fellows awarded $1.1 million for Alzheimer's disease research

FAU Brain Institute fellows awarded $1.1 million for Alzheimer's disease research

Study uncovers novel details about vulnerability of one brain cell to Alzheimer's

Study uncovers novel details about vulnerability of one brain cell to Alzheimer's

Advanced method can help detect multiple markers that contribute to Alzheimer's disease

Advanced method can help detect multiple markers that contribute to Alzheimer's disease

Neural mapping approach to re-examine previous Alzheimer's studies finds improved reproducibility

Neural mapping approach to re-examine previous Alzheimer's studies finds improved reproducibility

Research opens door to development of drug or vaccine for late-onset Alzheimer's

Research opens door to development of drug or vaccine for late-onset Alzheimer's

Immune cells explode themselves to inform about the danger of invading bacteria

Immune cells explode themselves to inform about the danger of invading bacteria

Assisted living’s breakneck growth leaves patient safety behind

Assisted living’s breakneck growth leaves patient safety behind

Study focuses on modification of lipid nanoparticles for successful brain cell targeting

Study focuses on modification of lipid nanoparticles for successful brain cell targeting

Researcher conducts study to investigate peripheral blood markers of Alzheimer's disease

Researcher conducts study to investigate peripheral blood markers of Alzheimer's disease

Study finds epigenetic differences in the brains of individuals with schizophrenia

Study finds epigenetic differences in the brains of individuals with schizophrenia

Researchers use brain connectome to reassess neuroimaging findings of Alzheimer's disease

Researchers use brain connectome to reassess neuroimaging findings of Alzheimer's disease

Answering the Biggest Neurological Research Questions of Today

Answering the Biggest Neurological Research Questions of Today

New drug shows promise in treating sarcomas

New drug shows promise in treating sarcomas

Alzheimer's could possibly be spread via contaminated neurosurgery

Alzheimer's could possibly be spread via contaminated neurosurgery

Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer's disease

Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer's disease

Study uncovers new genetic clues to frontotemporal dementia

Study uncovers new genetic clues to frontotemporal dementia

UAlberta scientists identify biomarkers for detecting Alzheimer's disease in saliva samples

UAlberta scientists identify biomarkers for detecting Alzheimer's disease in saliva samples

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.